In October 2014, Shenzhen Yishi Kangning Biotechnology Co., Ltd. passed the ISO9001:2008 quality management system certification recognized by the National Certification and Accreditation Administration Committee. Hereby, I would like to express my gratitude to friends from all walks of life who have been following and supporting ISKCONN!

ISO9001 provides a scientific method and means of quality management and quality assurance for enterprises. The passing of the ISO9001 quality management system certification is another milestone on ISKCON's rapid development. This not only means that the company is improving its R&D, technical services and internal management, but also enhances the company’s market competitiveness. While further improving technical services and establishing corporate brand image, it also provides the company’s own intellectual property rights for ACTL anti-tumor cells. The future development of immunotherapy technology and related products has laid a solid foundation, and also provided a more powerful guarantee for the company's scientific and standardized management system.

Professor Liu Yong, Chief Scientist of ISKCON, said: "After ISKCON has passed the ISO9001 certification, it will continue to take a rigorous attitude, scientifically and standardizedly, to conduct the research and development of ACTL targeted anti-tumor cell immune technology and its products. Make ACTL, an international innovative technology, serve more patient groups as soon as possible."